A fund reduced its stake and boosted its position in Boston Scientific shares while retaining a buy or outperform rating.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A fund reduced its stake and boosted its position in Boston Scientific shares while retaining a buy or outperform rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
-
Amundi
French subsidiary jointly created by Crédit Agricole and Société Générale
-
UBS
Swiss multinational investment bank and financial services company